SMARCA4 and neoplasm: Similarly, SMARCA4-deficient MRTs, such as AT/RTs, have been noted for exhibiting high expression levels of EPHA5, indicating that the Ephrin signaling pathway may be tumor-promoting in SMARCA4-driven malignancies [56].